SunLink Health Systems Stock (AMEX:SSY), Trade Ideas

SunLink Health Systems

SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

ACLS

ACON

AFRM

ALLO

AMTD

AMZN

APWC

ATHX

AVCT

BEAM

BXRX

CAAS

CALA

CHEK

CLAR

CLEU

CRDO

CVAC

CVNA

DELL

DNMR

DOMO

DRUG

ELOX

EMBK

EVBG

FATE

FTCH

FWBI

GLTO

GSUN

HAIN

HSCS

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

LTRX

MEDS

MEGL

MFGP

MRVL

MSFT

MSPR

NEPT

NERV

NVDA

OTEX

PEAR

PRCH

PRDS

SAVA

SGEN

SLNO

SONX

STBX

SXTC

TEDU

TRUP

TYRA

UPST

VACC

VEEE

VIVK

VRAX

VTEX

WAFU

WDAY

WETG

Gainers


	Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.


Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday

Intraday Update

AKLI

APGN

GOGL

NBEV

ULTA

Gainers


	Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.


Why Farfetch Is Trading Higher By 32%, Here Are 46 Stocks Moving In Friday&#39;s Mid-Day Session

LMDX

LXEH

USEA

VGFC

ZYNE

Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket

SunLink Health Systems, Inc. Common Stock

SunLink Health Systems Inc

SENSYNE HEALTH LTD by Sensyne Health Ltd.

Sensyne Health PLC

Sassy Gold Corp

Stratasys Ltd

SSY Group Ltd

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is a 120.69 percent decrease over earnings of $0.29 per share from the same period last year. The company reported $8.51 million in sales this quarter. This is a 40.87 percent decrease over sales of $14.39 million the same period last year.

Earnings

SunLink Health Systems Q2 EPS $(0.06) Down From $0.29 YoY, Sales $8.51M Down From $14.39M YoY

Asset Sales

Sunlink Health Systems' Subsidiary Reaches Revised Agreements For Sale Of Trace Regional Medical Center And Clinics; Sold Property To Progressive For $500,000; Six-Month Net Lease For $20,000/Month; Terminates Nov. 10, 2023 Transaction

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is a 72.73 percent increase over losses of $(0.22) per share from the same period last year. The company reported $8.55 million in sales this quarter. This is a 22.49 percent decrease over sales of $11.04 million the same period last year.

SunLink Health Systems Q1 EPS $(0.06) Up From $(0.22) YoY, Sales $8.55M Down From $11.04M YoY

SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMERICAN#NYSE">AMERICAN</a>) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC ("Buyer") for the sale of the subsidiary that owns and operates Trace Regional Medical Center, which includes a hospital, skilled nursing facility and three (3) patient clinics in Chickasaw County, MS, for approximately $8,000,000. The sale is subject to, among other things, the Buyer's satisfactory completion of its due diligence investigation and a number of customary closing conditions. The company expects to recognize a pre-tax gain of approximately $1,700,000 on the transaction, which is scheduled to close on December 15, 2023. The transaction will therefore be reported in SunLink Health Systems, Inc.'s second fiscal quarter. The proceeds of the sale of approximately $7,500,000, after payment of closing costs, will be used for general corporate purposes.
As a result of the Company's agreement on November 10, 2023 to sell Trace Regional Medical Center, SunLink Health Systems, Inc. will delay its filing with the U. S. Securities and Exchange Commission ("SEC") of its quarterly report on Form 10-Q for the period ended September 30, 2023, which is due by November 14, 2023. Because of the sale date, the Company needs additional time to prepare its financial statements for the quarterly period ended September 30, 2023. A Form 12b-25 will be filed with the SEC which allows for an automatic extension of five calendar days to file the Form 10-Q and have it be considered a timely filing. SunLink Health Systems, Inc. intends to file its Form 10-Q report of the quarterly period ended September 30, 2023 by the end of the five calendar day extension period.

Contracts

AMERICAN

SunLink Health Systems Reaches Agreement For Sale Of Trace Regional Medical Center For Approximately $8M

WIIM

SunLink Health Systems shares are trading lower. The company reported Q4 financial results.

SunLink Health Systems (AMEX:SSY) reported quarterly losses of $(0.20) per share. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported $10.99 million inSunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.20) per share. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported $10.99 million in sales this quarter. This is a 11.19 percent increase over sales of $9.88 million the same period last year.

SunLink Health Systems Q4 Reported Thursday EPS $(0.20) Up From $(0.33) YoY, Sales $10.99M Up From $9.88M YoY

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.11) per share. This is a 21.43 percent increase over losses of $(0.14) per share from the same period last year. The company reported $11.53 million in sales this quarter. This is a 9.56 percent increase over sales of $10.53 million the same period last year.

SunLink Health Systems Q3 EPS $(0.11) Up From $(0.14) YoY, Sales $11.53M Up From $10.53M YoY

Guidance

Sysco Corp Says Expect To End The Year Near The Bottom Of Adjusted EPS Fiscal 2023 Guidance Range Of $4-$4.15

Eugene Burleson Named Chairman of The Board
Forms Scientific Advisory Board Led by Academic Thought Leaders Dr. Bernard C. Camins at Mt. Sinai Health System, Dr. Christopher E. Mason at Cornell University and&nbsp;World-Renowned Winemaker Mark Beringer
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fapplieduvinc.com%2Fsterilumen%2F&amp;esheet=53378740&amp;newsitemid=20230411005175&amp;lan=en-US&amp;anchor=Applied+UV%2C+Inc.&amp;index=1&amp;md5=9fadd458916542faeb49eb82bde46e08">Applied UV, Inc.</a>&nbsp;(NasdaqCM:&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Firdirect.net%2FAUVI&amp;esheet=53378740&amp;newsitemid=20230411005175&amp;lan=en-US&amp;anchor=AUVI&amp;index=2&amp;md5=33f5003cec339c36192391140cce7e16">AUVI</a>) (&quot;Applied UV&quot; or the &quot;Company&quot;), a global leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, announces today the following leadership appointments following the completion of Applied UV&#39;s acquisition of Puro Lighting, LLC (&quot;PURO&quot;) and LED Supply Co. (&quot;LED Supply&quot;). Eugene Burleson who has served on Applied UV&#39;s Board of Directors since 2020 has been named Chairman of the Board. Max Munn, the Company&#39;s Founder, and a member of the Board of Directors and, has been serving as the interim CEO, has been appointed CEO and President of Applied UV. Brian Stern, chief executive officer and co-founder of PURO, and Andrew Lawrence, chief operating officer and co-founder of PURO and LED Supply have joined the Company&#39;s management team.
In addition, the Company has formed a Global Scientific Advisory Board and appointed Dr. Bernard C. Camins, Dr. Christopher E. Mason and Mark Beringer to serve as advisors.
Max Munn, Founder, CEO and Director stated, &quot;Gene Burleson has provided us sound counsel since he joined our Board. I championed his elevation to serve as our chairman. Having two of the founders join our ranks will help to ensure timely execution of the integration of Puro and LED Supply. The addition of these distinguished thought leaders to our Scientific Advisory Board will help drive the adoption of our entire suite of air and surface pathogen elimination portfolio by our customers and potential customers. We welcome all these esteemed individuals to the Applied UV Family.&quot;
Mark Beringer, a member of Applied UV&#39;s Scientific Advisory Board and Chief Wine Maker at Phantom Creek Estates in the Okanagan Valley, BC stated, &quot;We utilize our Airocide systems to protect our most valued assets, our oak fermentation tanks. These vessels represent a huge investment, and they must be meticulously maintained from drying out or becoming contaminated with any foreign yeast, bacteria, molds, or mildews. We keep our rooms at a high level of relative humidity, so we count on the Airocide units to keep the air clean and free of any organism or Volatile Organic Compounds (&quot;VOCs&quot;) that could potentially damage the wood vessels or the wines within them. With Airocide our rooms are hospital level clean.&quot;
Executive Management and Board of Director Appointments
Eugene Burleson&nbsp;&ndash; Has been a member of our Board of Directors since our IPO. He is a private investor, currently a director and Chairman of the Compensation Committee of Sunlink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>), an investor in healthcare facilities and related businesses located in the Southeast, and a director and the Chairman of the Compensation Committee of HealthNow New York, a private health insurance company. He was Chairman of PET DRx Corporation from June 2005 to July 1, 2010, and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010. Mr. Burleson was a director of HealthMont Inc. from September 2000 until its acquisition by SunLink in October 2003. Mr. Burleson served as Chairman of the Board of Directors of Mariner Post-Acute Network, Inc. from January 2000 to June 2002. Mr. Burleson also served as Chairman of the Board of Directors of Alterra Healthcare Inc., a developer and operator of assisted living facilities and is on the Board of Deckers Outdoor Corporation Inc. Mr. Burleson served as Chairman of the Board and Chief Executive Officer of GranCare Inc. from October 1988 to November 2000. Additionally, Mr. Burleson served as President and Chief Executive Officer of GranCare Inc. from December 1990 to February 1997. Upon completion of the merger of GranCare&#39;s pharmacy operations with Vitalink Pharmacy Services Inc. in February 1997, he became Chief Executive Officer and a Director of Vitalink Pharmacy Services Inc. Mr. Burleson resigned as Chief Executive Officer and Director of Vitalink Pharmacy Services in August 1997. From June 1986 to March 1989, Mr. Burleson served as President, Chief Operating Officer, and a Director of American Medical International Inc. (&quot;AMI&quot;), an owner and operator of acute care hospitals. Based in London from May 1981 to June 1986, Mr. Burleson served as Managing Director of AMI&#39;s international operations. Mr. Burleson received his early management training at Eastman Kodak from 1963 to 1974. He graduated from East Tennessee State University with a Bachelor of Science Degree in accounting and earned an MBA degree in 1972.
Brian Stern and Lawrence Webb join Applied UV&#39;s leadership team as the Company continues the global market expansion of its patented, disruptive, and highly effective suite of surface and air pathogen elimination and disinfection solutions, which now includes the PURO and LED Supply suite of products. Mr. Stern has been appointed to the role of President of PURO Lighting and will serve as a Director on the Board of Applied UV. Mr. Webb has been appointed to the role of president of LED Supply.
Brian Stern&nbsp;most recently served as chief executive officer and co-founder of PURO Lighting Inc. and LED Supply Co. which merged with Applied UV in January 2023. Brian is a visionary entrepreneur and University of Denver alum with a BS in Business Administration who has made a significant impact in the business world. With the co-founding of LED Supply Co. in 2007 and Puro Lighting in 2019, Brian established himself as a leader in both the LED lighting and UV disinfection markets. Under his direction, LED Supply. was recognized multiple times by&nbsp;Inc. Magazine&nbsp;as one of the fastest growing companies in the country. With Puro, Brian secured some of the largest contracts for UV disinfection and implemented cutting-edge UVC technology on a nationwide scale. As CEO of both companies, Brian drove their meteoric rise to become one of the fastest growing companies in the United States.
Andrew Lawrence&nbsp;most recently served as chief operating officer and co-founder of PURO Lighting Inc., and LED Supply. He began his professional career in the radio ad sales industry working for a top Denver station where he developed his skills as a salesperson to quickly became the top revenue generator for the firm. In 2009, Andrew co-founded LED Supply Co. with his partner, Brian Stern. As a small business owner/operator, Andrew gained extensive experience in people management, human resources, business operations, key account development and business strategy. In 2018, together with Mr. Stern and Jim Colantoni, Andrew co-founded PURO Lighting, providing ground-breaking UV light technology to help bring clinical-level disinfection to wherever people gather. As Andrew moves into his new role as president of LED Supply, he has the benefit of continuing to manage and work with the same strong team of people he has developed over the past 14 years.

Management

AUVI

Applied UV Strengthens Leadership With Executive And Board Appointments; Eugene Burleson Named Chairman Of The Board

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly earnings of $0.29 per share. This is a 514.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported $14.39 million in sales this quarter. This is a 38.24 percent increase over sales of $10.41 million the same period last year.

SunLink Health Systems Q2 EPS $0.29 Up From $(0.07) YoY, Sales $14.39M Up From $10.41M YoY